Understanding and Improving Anticoagulation Dosing for Patients With Atrial Fibrillation
NCT03719144 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 581
Last updated 2023-09-05
Summary
This study will survey atrial fibrillation patients to better understand patient perspective of DOAC treatment, and providers to assess knowledge, practice patterns, and beliefs surrounding anticoagulation for AF.
Conditions
Sponsors & Collaborators
- collaborator INDUSTRY
- lead OTHER
Principal Investigators
-
Tracy Y Wang, MD · Duke Clinical Research Institute, Duke University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-08
- Primary Completion
- 2020-03-24
- Completion
- 2020-03-24
Countries
- United States
Study Locations
More Related Trials
-
Atrial Fibrillation Incidence, Risk Factors and Genetics
NCT00021905 ·Status: COMPLETED
-
A Study to Quantify Use of Anticoagulation to Improve Management of Atrial Fibrillation
NCT03382613 ·Status: TERMINATED
-
Study of a New Anticoagulant Drug in Patients With Atrial Fibrillation
NCT00431782 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Anticoagulant, and Associated Factors of Anticoagulant Refusal Atrial Fibrillation Patients
NCT04062071 ·Status: UNKNOWN
-
Evaluation of Hospital Readmissions Among Hospitalized Non-valvular Atrial Fibrillation (NVAF) Patients in the US
NCT02674594 ·Status: COMPLETED
-
IMplementation of an RCT to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation
NCT03259373 ·Status: COMPLETED ·Phase: NA
-
Markers of Oxidative Stress Present in Blood in Patients With Atrial Fibrillation
NCT00142194 ·Status: COMPLETED
-
Atrial Fibrillation (AF) Ablation to Prevent Disease Progression of AF-induced Atrial Cardiomyopathy in Women and Men
NCT06200311 ·Status: RECRUITING ·Phase: NA
-
Paroxysmal Atrial Fibrillation: Role of Inflammation, Oxidative Stress Injury and Effect of Statins
NCT00321802 ·Status: COMPLETED ·Phase: PHASE2
-
Management of Antithrombotic TherApy in Patients With Atrial Fibrillation or DevelOping AtRial Fibrillation During Hospitalization for PCI
NCT03656523 ·Status: COMPLETED
-
Application of "I-Anticoagulation"in Patients With Atrial Fibrillation
NCT06137794 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Rate
NCT05661942 ·Status: COMPLETED ·Phase: PHASE4
-
Atrial Fibrillation and Premature Atrial Complexes in Patients With Ischemic Stroke.
NCT02180542 ·Status: COMPLETED
-
ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1
NCT02569528 ·Status: COMPLETED
-
Anticoagulant and Antiarrhythmic Management Based on Continuous Rhythm Monitoring
NCT04038944 ·Status: UNKNOWN
-
Atherosclerosis in Atrial Fibrillation
NCT01882114 ·Status: UNKNOWN
-
A Study to Assess the Effectiveness of an Atrial Fibrillation (AF) Risk Prediction Algorithm and Diagnostic Test in Identifying Patients With AF.
NCT04045639 ·Status: COMPLETED
-
Cryoballoon vs. Rhythmia Guided Ablation for Recurrent AFib
NCT03811795 ·Status: UNKNOWN ·Phase: NA
-
Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE
NCT05293080 ·Status: RECRUITING ·Phase: PHASE3
-
AF at Home: A Virtual Education Program for Patients With Atrial Fibrillation (AF)
NCT05810896 ·Status: COMPLETED ·Phase: NA
-
Prospective Elimination Of Distal Coronary Sinus-Left Atrial Connections for Atrial Fibrillation Ablation Trial
NCT03646643 ·Status: COMPLETED ·Phase: NA
-
Reversal of Atrial Substrate to Prevent Atrial Fibrillation Pilot Study
NCT03186976 ·Status: COMPLETED ·Phase: NA
-
Rhythm Control Versus Rate Control for New Onset Atrial Fibrillation
NCT05950971 ·Status: TERMINATED ·Phase: NA
-
Prediction of Bleeding Risk After Anticoagulant Therapy for Atrial Fibrillation Based on Proteomics and Metabolomics
NCT05181774 ·Status: UNKNOWN
-
Treatment and Outcomes of Atrial Fibrillation and Acute Coronary Syndrome in Sweden
NCT03311139 ·Status: COMPLETED